Literature DB >> 26569580

Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy.

Christopher E M Griffiths1, Michael R Barnes2, A David Burden3, Frank O Nestle4, Nick J Reynolds5, Catherine H Smith4, Richard B Warren6, Jonathan N W N Barker4.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26569580     DOI： 10.1038/jid.2015.286

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  12 in total

1.  Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes.

Authors:  C N Ellis; G G Krueger
Journal:  N Engl J Med       Date:  2001-07-26       Impact factor: 91.245

2.  Lebrikizumab treatment in adults with asthma.

Authors:  Jonathan Corren; Robert F Lemanske; Nicola A Hanania; Phillip E Korenblat; Merdad V Parsey; Joseph R Arron; Jeffrey M Harris; Heleen Scheerens; Lawren C Wu; Zheng Su; Sofia Mosesova; Mark D Eisner; Sean P Bohen; John G Matthews
Journal:  N Engl J Med       Date:  2011-08-03       Impact factor: 91.245

Review 3.  Secukinumab: first global approval.

Authors:  Mark Sanford; Kate McKeage
Journal:  Drugs       Date:  2015-02       Impact factor: 9.546

4.  British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

Authors:  C H Smith; A V Anstey; J N W N Barker; A D Burden; R J G Chalmers; D A Chandler; A Y Finlay; C E M Griffiths; K Jackson; N J McHugh; K E McKenna; N J Reynolds; A D Ormerod
Journal:  Br J Dermatol       Date:  2009-11       Impact factor: 9.302

Review 5.  Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease.

Authors:  Gary P Anderson
Journal:  Lancet       Date:  2008-09-20       Impact factor: 79.321

6.  Clearance of psoriasis with low dose cyclosporin.

Authors:  C E Griffiths; A V Powles; J N Leonard; L Fry; B S Baker; H Valdimarsson
Journal:  Br Med J (Clin Res Ed)       Date:  1986-09-20

7.  Stratified medicines: towards better treatment for disease.

Authors:  John Bell
Journal:  Lancet       Date:  2014-02-26       Impact factor: 79.321

8.  Psoriasis: a disease of abnormal Keratinocyte proliferation induced by T lymphocytes.

Authors:  H Valdimarsson; B S Bake; I Jónsdótdr; L Fry
Journal:  Immunol Today       Date:  1986-09

9.  The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives.

Authors:  A D Burden; R B Warren; C E Kleyn; K McElhone; C H Smith; N J Reynolds; A D Ormerod; C E M Griffiths
Journal:  Br J Dermatol       Date:  2012-03       Impact factor: 9.302

10.  A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1.

Authors:  Amy Strange; Francesca Capon; Chris C A Spencer; Jo Knight; Michael E Weale; Michael H Allen; Anne Barton; Gavin Band; Céline Bellenguez; Judith G M Bergboer; Jenefer M Blackwell; Elvira Bramon; Suzannah J Bumpstead; Juan P Casas; Michael J Cork; Aiden Corvin; Panos Deloukas; Alexander Dilthey; Audrey Duncanson; Sarah Edkins; Xavier Estivill; Oliver Fitzgerald; Colin Freeman; Emiliano Giardina; Emma Gray; Angelika Hofer; Ulrike Hüffmeier; Sarah E Hunt; Alan D Irvine; Janusz Jankowski; Brian Kirby; Cordelia Langford; Jesús Lascorz; Joyce Leman; Stephen Leslie; Lotus Mallbris; Hugh S Markus; Christopher G Mathew; W H Irwin McLean; Ross McManus; Rotraut Mössner; Loukas Moutsianas; Asa T Naluai; Frank O Nestle; Giuseppe Novelli; Alexandros Onoufriadis; Colin N A Palmer; Carlo Perricone; Matti Pirinen; Robert Plomin; Simon C Potter; Ramon M Pujol; Anna Rautanen; Eva Riveira-Munoz; Anthony W Ryan; Wolfgang Salmhofer; Lena Samuelsson; Stephen J Sawcer; Joost Schalkwijk; Catherine H Smith; Mona Ståhle; Zhan Su; Rachid Tazi-Ahnini; Heiko Traupe; Ananth C Viswanathan; Richard B Warren; Wolfgang Weger; Katarina Wolk; Nicholas Wood; Jane Worthington; Helen S Young; Patrick L J M Zeeuwen; Adrian Hayday; A David Burden; Christopher E M Griffiths; Juha Kere; André Reis; Gilean McVean; David M Evans; Matthew A Brown; Jonathan N Barker; Leena Peltonen; Peter Donnelly; Richard C Trembath
Journal:  Nat Genet       Date:  2010-10-17       Impact factor: 38.330
View more
  9 in total

Review 1.  Progress to Date in Advancing Stratified Medicine in Psoriasis.

Authors:  Claire Reid; Lis Cordingley; Richard B Warren; Christopher E M Griffiths
Journal:  Am J Clin Dermatol       Date:  2020-10       Impact factor: 7.403

2.  A Framework for Multi-Omic Prediction of Treatment Response to Biologic Therapy for Psoriasis.

Authors:  Amy C Foulkes; David S Watson; Daniel F Carr; John G Kenny; Timothy Slidel; Richard Parslew; Munir Pirmohamed; Simon Anders; Nick J Reynolds; Christopher E M Griffiths; Richard B Warren; Michael R Barnes
Journal:  J Invest Dermatol       Date:  2018-07-17       Impact factor: 8.551

3.  HLA-Cw6 homozygosity in plaque psoriasis is associated with streptococcal throat infections and pronounced improvement after tonsillectomy: A prospective case series.

Authors:  Ragna H Thorleifsdottir; Sigrun L Sigurdardottir; Bardur Sigurgeirsson; Jon H Olafsson; Hannes Petersen; Martin I Sigurdsson; Johann E Gudjonsson; Andrew Johnston; Helgi Valdimarsson
Journal:  J Am Acad Dermatol       Date:  2016-08-09       Impact factor: 11.527

Review 4.  Quantitative Evaluation of Biologic Therapy Options for Psoriasis: A Systematic Review and Network Meta-Analysis.

Authors:  Zarif K Jabbar-Lopez; Zenas Z N Yiu; Victoria Ward; Lesley S Exton; M Firouz Mohd Mustapa; Eleanor Samarasekera; A David Burden; Ruth Murphy; Caroline M Owen; Richard Parslew; Vanessa Venning; Richard B Warren; Catherine H Smith
Journal:  J Invest Dermatol       Date:  2017-04-27       Impact factor: 8.551

5.  Intentional and Unintentional Medication Non-Adherence in Psoriasis: The Role of Patients' Medication Beliefs and Habit Strength.

Authors:  Rachael J Thorneloe; Christopher E M Griffiths; Richard Emsley; Darren M Ashcroft; Lis Cordingley
Journal:  J Invest Dermatol       Date:  2017-11-26       Impact factor: 8.551

6.  CARD14 mutations may predict response to antitumour necrosis factor-α therapy in psoriasis: a potential further step towards personalized medicine.

Authors:  K C P Wu; N J Reynolds
Journal:  Br J Dermatol       Date:  2016-07       Impact factor: 9.302

Review 7.  Psoriasis and Genetics.

Authors:  Nick Dand; Satveer K Mahil; Francesca Capon; Catherine H Smith; Michael A Simpson; Jonathan N Barker
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

Review 8.  Psoriasis and Treatment: Past, Present and Future Aspects.

Authors:  Claire Reid; Christopher E M Griffiths
Journal:  Acta Derm Venereol       Date:  2020-01-30       Impact factor: 3.875

9.  Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasis.

Authors:  Richard B Warren; Nick J Reynolds; Christopher E M Griffiths; Jonathan N Barker; Catherine H Smith; Rosa Andres-Ejarque; Hira Bahadur Ale; Katarzyna Grys; Isabella Tosi; Shane Solanky; Chrysanthi Ainali; Zeynep Catak; Hemawtee Sreeneebus; Jake Saklatvala; Nick Dand; Emanuele de Rinaldis; Anna Chapman; Frank O Nestle; Michael R Barnes; Paola Di Meglio
Journal:  Nat Commun       Date:  2021-08-06       Impact factor: 14.919
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.